Drug Type Biological products |
Synonyms- |
Target |
Mechanism CD28 modulators(T-cell-specific surface glycoprotein CD28 modulators), CTLA4 modulators(Cytotoxic T-Lymphocyte-Associated Antigen 4 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | CH | 07 Nov 2022 |